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Abstract. Integrin receptors play important roles in or- 
ganizing the actin-containing cytoskeleton and in signal 
transduction from the extracellular matrix. The initial 
steps in integrin function can be analyzed experimen- 
tally using beads coated with ligands or anti-integrin 
antibodies to trigger rapid focal transmembrane re- 
sponses. A hierarchy of transmembrane actions was 
identified in this study. Simple integrin aggregation 
triggered localized transmembrane accumulation of 20 
signal transduction molecules, including RhoA, Racl, 
Ras, Raf, MEK, ERK, and JNK. In contrast, out of 
eight cytoskeletal molecules tested, only tensin coaccu- 
mulated. Integrin aggregation alone was also sufficient 
to induce rapid activation of the JNK pathway, with ki- 
netics of activation different from those of ERK. The 
tyrosine kinase inhibitors herbimycin A or genistein 
blocked both the accumulation of 19 out of 20 signal 
transduction molecules and JNK- and ERK-mediated 
signaling. Cytochalasin D had identical effects, whereas 
three other tyrosine kinase inhibitors did not. The sole 
exception among signaling molecules was the kinase 
pp125 FAK which continued to coaggregate with a5131 in- 
tegrins even in the presence of these inhibitors. Ty- 
rosine kinase inhibition also failed to block the ability 
of ligand occupancy plus integrin aggregation to trigger 
transmembrane accumulation of the three cytoskeletal 
molecules talin, et-actinin, and vinculin; these molecules 
accumulated even in the presence of cytochalasin D. 
However, it was necessary to fulfill all four conditions, 
i.e., integrin aggregation, integrin occupancy, tyrosine 
kinase activity, and actin cytoskeletal integrity, to 
achieve integrin-mediated focal accumulation of other 
cytoskeletal molecules including F-actin and paxillin. 
Integrins therefore mediate a transmembrane hierar- 
chy of molecular responses. 
I 
NTEGRIN receptors  for extracellular matrix molecules 
play central and complex roles in cell  interactions. 
They mediate cell adhesion, migration, and invasion, 
but they also have a multitude of intracellular effects on 
the organization of the  actin-containing cytoskeleton as 
well as roles in a variety of signaling processes (for reviews 
see  Hynes, 1992; Sastry and Horwitz, 1993; Juliano and 
Haskill,  1993; Gumbiner, 1993; Pavalko and Otey, 1994; 
Schaller and Parsons,  1994; Shattil et al., 1994a; Clark and 
Brugge, 1995). A complex series of steps leads from initial 
integrin interactions with an extracellular ligand to trans- 
membrane effects on the localization of cytoskeletal mole- 
cules or signaling molecules,  to the activation of signaling 
pathways, and to eventual regulation of gene expression. 
Identifying distinct  mechanisms of integrin responses  to 
extracellular stimuli and patterns in the classes of respond- 
ing molecules will be crucial for understanding how inte- 
grins function. 
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Extracellular interactions of integrins leading to specific 
cytoplasmic  responses  have  been  studied  in  many cell 
types,  particularly fibroblasts  and platelets. Besides  pro- 
viding insights into the activation of integrin ligand-bind- 
ing functions, studies of platelets have defined steps in the 
intracellular response to ligation of the major platelet inte- 
grin ailb133. Occupancy by monomeric soluble  ligand has 
no apparent effects, whereas divalent ligand can stimulate 
Syk activation (Clark et al.,  1994); however, two subse- 
quent waves of phosphorylation present in normal platelet 
aggregation require  immobilized  ligand,  platelet  activa- 
tion, and/or platelet-platelet aggregation (Shattil  et  al., 
1994a). For example, phosphorylation of 50-72  kD and 
140-kD proteins of unknown function occur on immobi- 
lized fibrinogen, while other responses  such as FAK (focal 
adhesion kinase)  phosphorylation require platelet-plate- 
let aggregation (Huang et al., 1993; Shattil  et al., 1994b). 
Platelet aggregation with immobilized ligand leads to ma- 
jor increases in association of anbl33 with large cytoskeletal 
complexes. This anchorage of integrin to the platelet cy- 
toskeleton occurs in parallel with immobilization of a vari- 
ety of kinases such as c-Src (Shattil et al., 1994a). One in- 
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limited aggregation of the ~Xttb[33 integrin provides a very 
rapid trigger for the first step of the intracellular response, 
and that the next steps are induced by the subsequent ag- 
gregation of these integrins and cells due to immobilized 
ligand  or platelet-to-platelet  aggregation.  However, this 
scenario is difficult to test directly in platelets due to their 
small size. 
Fibroblast systems have provided complementary infor- 
mation. A variety of signaling responses including calcium 
influx and changes in cytoplasmic pH have been identified 
(Schwartz et al.,  1991; Leavesley et al., 1993).  The phos- 
phorylation on tyrosine residues of focal adhesion kinase 
(also  termed pp125 FAK or FAK; for review see  Schaller 
and  Parsons,  1994)  has  been  intensively  studied.  FAK 
phosphorylation can be induced by antibody-induced clus- 
tering of intact integrins or even of molecular chimeras 
containing only the intracellular domain of the 131 integrin 
subunit (Kornberg et al., 1991; Akiyama et al., 1994). Inte- 
grin ligation can also trigger activation of certain MAP ki- 
nases,  specifically  extracellular  signal-regulated  kinase 
(ERK) 1 members (Chen et al.,  1994; Morino et al.,  1994; 
Schlaepfer et al.,  1994).  Other studies have linked ERK 
activation to growth factor response pathways, e.g., EGF 
receptor activation of growth. Other types of MAP kinases 
besides ERK1 and ERK2 have distinct pathways and func- 
tions (Davis, 1994; Oehlen and Cross, 1994). For example, 
SAPK (stress-activated protein kinase)/JNK (JUN kinase) 
is not activated by EGF receptors in most cell types, but 
instead becomes activated after treatment of cells by in- 
flammatory cytokines or after stresses such as UV irradia- 
tion (Derijard et al., 1994).  Comparisons of possible roles 
of integrins in activating these distinct signaling pathways 
should provide insights into the relationship of integrin li- 
gation and signal transduction to the nucleus. 
Cytoskeletal responses to integrin ligation can be ana- 
lyzed using beads coated with a variety of molecules that 
interact with  integrins.  Fibronectin-coated beads  induce 
the local accumulation of a variety of cytoskeletal mole- 
cules,  including  vinculin,  talin,  cx-actinin,  and  F-actin 
(Grinnell and Geiger, 1986; Mueller et al., 1989; Plopper 
and Ingber, 1993; Lewis and Schwartz, 1995).  The initial 
integrin response in fibroblasts can be dissected into three 
parts  using  soluble  ligands  vs  immobilized  multivalent 
ligands, and antibodies that can induce integrin aggrega- 
tion either with  or without effects on adhesive function 
(Miyamoto et al., 1995). There are distinct effects on inte- 
grin cytoskeletal function mediated by ligand  occupancy 
alone, by receptor aggregation alone, or by a combination 
of occupancy and aggregation. Ligand occupancy with sol- 
uble, monovalent ligand triggers fibroblast integrin local- 
ization to preexisting focal contacts, but does not trigger 
FAK phosphorylation. Direct integrin aggregation with- 
out  ligand  occupancy mediated  by noninhibitory mono- 
clonal antibodies triggers FAK phosphorylation as well as 
the local accumulation of FAK and the cytoskeletal pro- 
tein tensin in a focal location immediately adjacent to anti- 
integrin coated beads. However, a combination of integrin 
aggregation and occupancy by soluble ligand or antifunc- 
1. Abbreviations used in this" paper:  ERK, extracellular signal-regulated 
kinase; FAK, focal adhesion kinase; JNK, Jun kinase. 
tional antibodies triggers a synergistic response involving 
the accumulation of six other cytoskeletal proteins includ- 
ing talin and F-actin (Miyamoto et al., 1995). 
In this study, we explore the hypothesis that the extra- 
cellular triggering of an integrin response involves a series 
of specific stages or hierarchies of protein interactions. A 
substantial  number  of potential  intermolecular  interac- 
tions are already known, including evidence for the bind- 
ing of talin, tx-actinin, and FAK to the [~1 integrin cytoplas- 
mic  domain  (Horwitz  et  al.,  1986;  Otey  et  al.,  1990; 
Schaller and Parsons, 1994; Lewis and Schwartz, 1995). In 
addition, there is accumulating evidence to suggest the ex- 
istence of protein-protein interactions among cytoskeletal 
proteins and a variety of signaling molecules (for a review 
see Clark and Brugge, 1995).  Because so many proteins 
can potentially interact with each other based on in vitro 
studies, it is important to determine whether there are spe- 
cific patterns or hierarchies of interactions induced by in- 
tegrins within the cytoplasmic milieu. 
In the present study, we have compared a series of over 
20  proteins  implicated  in  various  signal  transduction 
events with a variety of cytoskeletal proteins using a bead- 
binding system that permits local experimental triggering 
of transmembrane responses. These responses were then 
dissected using inhibitors of tyrosine phosphorylation and 
actin integrity to search for differential requirements. The 
goal was  to  identify hierarchies  of interaction,  since  so 
many molecules appear to contribute to integrin-induced 
complexes (e.g., see molecules already identified by Bur- 
ridge et al., 1988; Plopper and Ingber, 1993; Miyamoto et 
al., 1995). 
Using this approach, we have classified 32 signal-trans- 
duction and cytoskeletal proteins into at least five distinct 
groups depending on their ability to form juxtamembrane 
complexes in response to signals involving (a) the state of 
integrin receptor aggregation, (b) integrin occupancy, (c) 
cytoplasmic tyrosine phosphorylation,  and  (d)  actin  cy- 
toskeletal integrity. Of these stimuli involved in complex 
formation, three appear to be required for integrin-medi- 
ated activation of the ERK and JNK pathways, which are 
thought to be common intermediaries in many membrane- 
nuclear signaling processes. Our studies provide the first 
detailed comparative analysis of the requirements for inte- 
grin-mediated regulation of families of signal transduction 
and cytoskeletal molecules. 
Materials and Methods 
Cell Culture and Bead Assays 
Human foreskin fibroblasts were cultured in DME medium supplemented 
with 10% heat-inactivated FBS (Hyclone, Logan, UT), 1 mM glutamine, 
50 ~g/ml streptomycin, and 50 U/ml penicillin. The cells were a generous 
gift from Dr. Steve Alexander (Bethesda Research Laboratories, Gaith- 
ersburg, MD), and were used at cell passages 9-18. 
Latex beads  (mean diameter  11.9  p,m,  Sigma Chem. Co.,  St.  Louis, 
MO) were coated with ligand or antibody and incubated with ceUs exactly 
as described previously for the experimental induction of focal integrin 
clustering  and  transmembrane accumulation of cytoplasmic molecules 
(Miyamoto et al., 1995).  After 20 min incubation with beads, cells were 
fixed in PBS with 4% paraformaldehyde and 5 % sucrose, and analyzed by 
immunofluorescence microscopy as  described  (LaFlamme et  al.,  1992; 
Miyamoto et al.,  1995)  using a  Nikon HFX-II microscope equipped for 
flnorescein and rhodamine fluorescence. In experiments using mouse anti- 
131 K20 antibody on beads, an excess of rat monoclonal anti-mouse IgG2a 
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the FITC-labeled secondary rat monoclonal anti-mouse IgG1 antibodies. 
Immunological Reagents 
Antibodies to integrins used to coat the latex beads were rat monoclonal 
antibodies mAb 11 and mAb 16 to the a5 integrin subunit and mAb 13 to 
the 13t integrin subunit  (Akiyama  et al.,  1989; LaFlamme et al.,  1992). 
Mouse monoclonal antibody K20  to  the  131  integrin subunit was from 
AMAC (Westbrook, ME). The following polyclonal antibodies were pur- 
chased and shown to be monospecific by Western immunoblotting using 
goat anti-rabbit IgG conjugated with peroxidase (Pierce Co., Rockford, 
IL): c-Src, c-Fyn, c-Csk, c-Lyn, PLC-~, PTP-1D (Syp), RhoA, Racl, Grb2, 
Rafl, MEK kinase, MEK1, ERK1, ERK2, JNK1 (Santa Cruz Biotechnol- 
ogy Santa Cruz, CA); c~-actinin (ICN Biomedicals, Costa Mesa, CA); Ras 
and GAP (Upstate Biotechnology, Lake Placid, NY); PI 3-kinase and Sos 
(Transduction  Laboratories,  Lexington, KY).  A  c-Yes polyclonal  anti- 
.  body also displayed a single band by Western immunoblotting using goat 
anti-rabbit IgG conjugated with peroxidase (Amersham Corp., Arlington 
Heights, IL). Monoclonal antibodies also confirmed as monospecifie by 
Western immunoblotting using goat anti-mouse lgG conjugated with per- 
oxidase (Amersham Corp.) were paxillin, tensin, ppl20, and protein ki- 
nase A  (Transduction Laboratories); filamin (Serotec, Indianapolis, IN); 
cortactin (Upstate Biotechnology); a-tubulin and LDH (Sigma); and vin- 
culin.  A  FAK  monoclonal  antibody  from  Transduction  Laboratories 
showed a single band using goat anti-mouse IgG conjugated with peroxi- 
dase (Pierce). Rhodamine-labeled phalloidin was from Molecular Probes 
(Eugene, OR). Integrin aggregation was determined for each ligand using 
rabbit antibodies 4318 and 4080 directed against the a5 and 131 integrin cy- 
toplasmic domains, respectively (Larjava  et al.,  1990; LaFlamme et al., 
1992; Miyamoto et al., 1995). Monospecific rabbit anti-talin antiserum was 
kindly provided by Dr. Keizo Takenaga,  and mouse monoclonal VII F9 
Bll  anti-human vinculin by Dr. Victor Koteliansky. FITC- and rhoda- 
mine-labeled secondary antibodies were obtained from BioSource Inter- 
national (Camarillo, CA). 
Use of  lnhibitors 
Dose response curves were evaluated for selective tyrosine kinase inhibi- 
tors including the anti-Src agents genistein and herbimycin A  and anti- 
EGF receptor inhibitors tyrphostin A23, tyrphostin A25, and erbstatin an- 
alog (Calbiochem Novabiochem Corp., San Diego, CA). Cells were cul- 
tured with each tyrosine kinase inhibitor at various concentrations for 24 h, 
and then incubated in medium with fibronectin-depleted  serum and 25 Ixg/ 
ml cycloheximide for 2 h as for other beads assays in the continual pres- 
ence  of inhibitor,  and  then  suspended  by  trypsinization.  When  using 
genistein and herbimycin A, cells required 2 h rather than the usual 1 h to 
spread  fully  on  the  collagen-coated coverslips before  the  addition  of 
beads. To monitor the cytotoxicity of agents, total cell number was deter- 
mined with a Coulter counter after 24 h incubation. Cytochalasin D  was 
purchased from Calbiochem; for assays, cytochalasin D  and beads were 
added simultaneously to cells on collagen-coated coverslips and assayed 
as described (Miyamoto et al., 1995). 
Extraction of Total Cell Protein and Proteins 
Bound to Beads 
Cells were incubated with fibronectin depleted serum and 25 tzg/ml cyclo- 
heximide, as described above. To assess the effect of each pharmacologi- 
cal agent on protein tyrosine phosphorylation, cells were rinsed with se- 
rum-free medium and incubated without serum for 1 h, and then cells (5 × 
105) in 1 ml serum-free medium were incubated with 107 beads for 20 min 
at 37°C. The cells were rinsed with PBS containing 1 mM sodium ortho- 
vanadate, and then lysed with RIPA buffer (1% Triton X-100, 1% sodium 
deoxycholate, 0.1%  SDS, 150 mM NaC1, 50 mM Tris, pH 8.0, 0.2  U/ml 
aprotinin, 2/xg/ml leupeptin, 1 ixg/ml pepstatin A, 2 mM PMSF, 1 mM so- 
dium orthovanadate). 
To  identify the proteins bound to  beads, cells were  suspended (107 
cells/ml) in serum-free medium with the beads (~2  x  108) and rotated 
gently for 20 rain at 37°C. The complex of beads and cells was then washed 
with modified CSK extraction buffer (0.5% Triton X-100,  50 mM NaC1, 
300 mM sucrose, 3 mM MgClz, 3 mM MnC12, 0.2 U/ml aprotinin, 2 ixg/ml 
leupeptin, 1 Ixg/ml pepstatin A, 2 mM PMSF, 10 mM Pipes [1,4 pipera- 
zinediethanesulfonic acid], 40 mM sodium pyrophosphate, 50 mM sodium 
fluoride, 1 mM sodium orthovanadate) without detergent at 4°C. The pel- 
let containing beads and cells was suspended with CSK buffer, and then 
Figure  1.  Integrin-induced  transmembrane  aggregation  of  Src 
kinase  family members, Src substrates, and signaling molecules 
by  individual  ligand-coated  beads. A.  Immunofluorescence  for 
juxtamembrane  accumulation  of  tyrosine-phosphorylated  pro- 
teins, c-Src, and c-Lyn induced by beads coated with fibronectin 
or polylysine. Each inset shows a  higher magnification view, fo- 
cusing on the equator of the bead marked by a highlighted black 
arrowhead; white arrowhead  indicates a  second bead bound to 
the  cell,  Fibronectin-coated  beads  induce  localization  of  ty- 
rosine-phosphorylated proteins after 20 min (a). The same cell is 
shown in the panel below by combined transmitted light and flu- 
orescence to illuminate the bead (c). Immunolocalization of c-Src 
protein  is  also  found  adjacent  to  fibronectin-coated beads  (e). 
Lack of tyrosine-phosphorylated protein adjacent to polylysine- 
coated beads is observed (b), plus transmitted light to illuminate 
the bead (d); absence of c-Src immunolocalization (f). No immu- 
nostaining  of c-Lyn  protein  adjacent  to  either  fibronectin-  or 
polylysine-coated beads is observed (g and h). 
(Continued next page) 
Miyamoto et al. lntegrin Cytoskeletal  and Signaling Hierarchies  793 Figure 1. (B) Quantitation of bead-induced accumulation of Src family kinases, Src substrates, and signaling molecules with an SH2 do- 
main as assessed by immunofluorescence microscopy. The ordinate indicates the percentage of beads positive for immunofluorescence 
for each antigen listed on the abscissa; values indicate mean and standard deviation. Polystyrene beads were coated with one of the fol- 
lowing ligands: fibronectin, GRGDSPC  peptide disulfide--conjugated to IgG (multivalent immobilized RGD  ligand) according to the 
methods of Humphries et al. (1987), adhesion-blocking antibodies mAb 16 to the integrin a5 subunit and mAb 13 to the 131 subunit, non- 
inhibitory antibodies mAb 11 to the c~  5 subunit and mAb K20 to the 131 subunit, or Con A  and polylysine as control beads. Bar, (A) 
20 p.m. 
sonicated for 10 s using a micro-ultrasonic cell disruptor (Kontes). The 
beads-protein complexes were collected by centrifugation in a microcen- 
trifuge (15,000  rpm, 10 min) and the pellet was vigorously washed three 
times with CSK buffer. Proteins were extracted in RIPA buffer (Plopper 
and Ingber, 1993), and then subjected to SDS-PAGE and Western immu- 
noblotting. 
Assessment of SerinelThreonine Kinase Activation 
Cells were preincubated with fibronectin-depleted serum with or without 
25  i~g/ml cycloheximide, detached with trypsin-EDTA, washed with se- 
rum-free medium, and incubated in serum-free medium for 1 h. Cells (2 × 
106) in 500 txl were incubated with 4  ×  107 beads at 37°C. For measure- 
ment of ERK activity, cells were extracted with 1% NP-40, 20 mM Hepes, 
pH 7.5, 10 mM EGTA, 40 mM 13-glycerophosphate, 2 mM NaaVO4, 1 mM 
DTT,  2.5  mM  MgCI2,  20  ixg/ml  aprotinin,  20  ~g/ml leupeptin,  1  mM 
PMSF. Both ERK1  and ERK2 protein were immunoprecipitated at 4°C 
using  anti-ERK1  or  anti-ERK2  antibody (Santa  Cruz  Biotechnology), 
which has a cross reactivity to both ERK1 and ERK2 protein, and then 
with protein G  Sepharose for 1 h. To analyze the activation of SAPK/ 
JNK, cells were extracted with 0.1% Triton, 300 mM NaC1, 25 mM Hepes, 
pH 7.5, 0.2 mM EDTA, 20 mM 13-glycerophosphate, 1 mM Na3VO4,  1.5 
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Figure 2.  Comparisons of the 
effects of inhibitors on aggre- 
gation  induced  by  fibronec- 
tin-coated  beads  of  integrin 
receptors  and  tyrosine-phos- 
phorylated  proteins,  cell 
number,  and  total  cell  ty- 
rosine phosphorylation. Cells 
were pretreated for 24 h with 
the  tyrosine  kinase  inhibi- 
tors herbimycin A, genistein, 
tyrphostin  23,  tyrphostin  25, 
or erbstatin analog, as well as 
the actin  cytoskeletal inhibi- 
tor cytochalasin D. The ordi- 
nate indicates the percentage 
of beads  positive for immu- 
nofluorescence  accumulation 
of  the  (~5  integrin  subunit 
(hatched bars) compared  to 
tyrosine-phosphorylated pro- 
teins (open bars) at the inhib- 
itor concentrations  indicated 
on  the  abscissa;  values indi- 
cate mean and standard devi- 
ation. As an indicator of gen- 
eral cell viability and health, 
the filled circles indicate the 
mean cell number after 24 h 
at  each  inhibitor  concentra- 
tion  with  standard  devia- 
tions. For these experiments, 
human  foreskin  fibroblasts 
were seeded  at  105  cells per 
dish.  After 24  h, cell counts 
had reached 2.1  ±  0.2 ×  105. 
Inhibitors  were  then  added 
for an additional 24 h before 
assay  with  ligand-coated 
beads.  Additional  informa- 
tion  on  cytoxicity  obtained 
by  phase  contrast  micros- 
copy: herbimycin A  concen- 
trations of more than 1,300 nM resulted in loss of most cells, and at concentrations greater than 1,000 nM, cells were defective in attach- 
ment to collagen-coated coverslips and substantial cell debris was present. Genistein treatment at concentrations more than 220 I~M 
resulted in cell death, and significant quantities of cell debris was observed above 140  t~M. At concentrations greater than 200 ~M of 
tyrphostin A23 or A25, there were large amounts of cellular debris. A  concentration of 5 Ixg/ml erbstatin analog resulted in substantial 
amounts of cell debris, while 2.5 Ixg/ml had minimal visible cytotoxicity. Treatment by cytochalasin had no effects on cell viability ac- 
cording to trypan blue staining (data not shown). Stocks of all agents were in DMSO. No cell toxicity was detected after incubation for 
24 h with 5 ixl/ml DMSO. At 15 ixl/ml DMSO, no effects were observed on the aggregation of tyrosine-phosphorylated proteins after in- 
cubation for 24 h. In this study, DMSO was limited to less than 2 t~l/ml for all agents. 
mM MgC12, 0.5 mM D'I~r, 20 ~g/ml leupeptin,  1 mM PMSF, and SAPK/ 
JNK was precipitated  with  1 ~g of GST c-jun79 protein at 4°C for 3 h 
(Coso et al., 1995). These complexes were washed three times with PBS 
containing  1% NP-40 and 2 mM Na3VO4, once with the Tris buffer (100 
mM Tris, pH 7.5, 500 mM LiCl), and then once with kinase reaction buffer 
(12.5 mM MOPS, pH 7.5, 12.5 mM 13-glycerophosphate, 7.5 mM MgC12, 
0.5 mM EGTA, 0.5 mM NaF, 0.5 mM Na3VO4). 
For assaying ERKs, the immunocomplex was incubated with kinase re- 
action buffer containing 1 i~Ci [~32p]ATP, 20 I~M cold ATP, 3.3 i.tM DTT 
and 1.5 mg/ml myelin basic protein (MBP; Sigma) as a substrate  for ERK 
at 30°C for 20 min. For assaying SAPK/JNK, the complexes were incu- 
bated with kinase reaction buffer containing I p~Ci [~/~2P]ATP,  20/~M cold 
ATP, and 3.3 IzM DTT at 30°C for 30 min. These samples were then sus- 
pended in Laemmli buffer,  heated at 100°C for 5 min, and analyzed  by 
SDS-PAGE. Using gel slices for each  sample,  radioactivity  was deter- 
mined with a  liquid  scintillation  counter (LS 6000IC, Beckman Instrs., 
Fullerton,  CA). 
Results 
Experimentally Induced Aggregation of Members of 
the Src Kinase Family, Src Substrates, and Signaling 
Molecules with SH2 Domains at Cell-Matrix 
Contact Sites 
Beads  coated with extracellular matrix ligands such  as fi- 
bronectin  can  mimic  adhesion  site  generation,  and  they 
can induce transmembrane  aggregation of a  variety of cy- 
toskeletal molecules. This rapid,  massive accumulation of 
proteins  associated  with  the  actin  cytoskeleton  requires 
that  integrin  receptors  be  both  aggregated  and  occupied 
by ligand (Miyamoto et al., 1995). To explore whether sig- 
Miyamoto et al. Integrin Cytoskeletal  and Signaling Hierarchies  795 Figure 3.  Effects on the aggregation of specific cytoskeletal proteins and signal transduction molecules of herbimycin A, genistein, or 
cytochalasin D. (A) Immunofluorescence for juxtamembrane accumulation of tyrosine-phosphorylated proteins, F-actin, and tensin in- 
duced by beads coated with fibronectin. Each inset shows a higher magnification view, focusing on the equator of the bead marked by a 
highlighted black arrowhead; white arrowhead indicates a second bead bound to the cell. Localization of tyrosine-phosphorylated pro- 
teins  (a-c) and F-actin (d-f) becomes undetectable  after treatment with each of these three agents when assayed using fibronectin- 
coated beads. In contrast, tensin accumulation is unaffected (g-i). (B) Quantitation of bead-induced accumulation of cytoskeletal and 
signaling molecules with or without inhibitors. The ordinate indicates the percentage of beads positive for immunofluorescence accumu- 
lation of each antigen listed on the abscissa; values indicate mean and standard deviation. Polystyrene beads were coated with each of 
the following ligands:  fibronectin, GRGDSPC peptide disulfide conjugated to IgG, adhesion-blocking mAb 16 to a5 subunit and mAb 
13 to ~1 subunit, or noninhibitory mAb 11 to the a5 subunit and mAb K20 to the 131 subunit. Bar: (A) 20 txm. 
nal transduction molecules can also be physically redistrib- 
uted  into  these  localized  sites  by  a  transmembrane  pro- 
cess,  whether  they  can  be  functionally  activated  with 
specific  time  courses,  and  what  triggering  mechanisms 
might be involved, we examined  a  number of proteins  in- 
volved in signaling pathways involving tyrosine  phospho- 
rylation. Tyrosine-phosphorylated  proteins were recruited 
to  contact  sites  by  beads  coated  with  fibronectin  as  ex- 
pected  (Fig.  1 A). Multivalent  ligands  and both adhesion- 
blocking  and  noninhibitory  antibodies  coated  on  beads 
also effectively induced  transmembrane  aggregation of ty- 
rosine-phosphorylated proteins (Fig. 1 B). 
Antibodies  against specific signaling proteins were used 
to classify the types of molecule that accumulated.  The ty- 
rosine  kinases  FAK,  c-Src,  c-Fyn,  c-Yes,  and  c-Csk were 
recruited  to  large  adhesion  complexes  within  20  rain  ac- 
cording  to  immunofluorescence  microscopy  after  induc- 
tion of complexes by fibronectin,  multivalent  ligands,  ad- 
hesion-blocking  antibody, or even noninhibitory  antibody 
immobilized on beads (Fig.  1, A  and B). However, no sig- 
nificant  clustering  of the  kinase  c-Lyn could  be observed 
with any type of bead tested (Fig. 1, A  and B). 
FAK and tensin appear to be particularly proximally re- 
cruited to these contact sites (Miyamoto et al., 1995),  and 
both  are  potential  Src  substrates  (Schaller  et  al.,  1993). 
The recruitment of two other Src substrates was therefore 
compared.  Immunofluorescence  with  anti-pl20  and  cort- 
actin  antibodies  revealed  a  similarly  striking  transmem- 
brane clustering near ligand-coated beads. Accumulations 
were  induced  even  by  noninhibitory  antibody-coated 
beads, which could induce integrin and target molecule ag- 
gregation even in the absence of ligand occupancy (Fig. 1 B). 
In  addition,  other  signaling  molecules  that  contain  an 
SH2 domain for interactions with tyrosine phosphorylated 
sites  showed  substantial  aggregation  at  contact  sites  of 
beads, including  those coated with noninhibitory  antibod- 
ies (Fig. 1 B). Although noninhibitory antibodies on beads 
also  induced  focal  accumulations,  the  extent  of aggrega- 
tion  appeared  quantitatively  lower  when  compared  to 
complexes triggered by fibronectin, multivalent ligands, or 
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Our  protein localization results obtained using immu- 
nofluorescence were confirmed for several proteins using 
a modification of the method of Plopper and Ingber (1993; 
see Materials and Methods), which provides a method to 
detect biochemically the proteins associated with beads in 
focal adhesion-like complexes. The cytoskeletal and  sig- 
naling molecules vinculin, paxillin, c-Src, GAP, and PI 
3-kinase were found to be significantly enriched in associa- 
tion  with  fibronectin-coated  beads  compared  to  poly- 
lysine-coated beads (data not shown). 
Taken together, these findings indicate that Src kinase 
family members, Src substrates, and many other (but im- 
portantly  not  all)  signaling  molecules contribute  to  the 
protein complex that is experimentally induced at matrix 
contact sites.  Unlike many cytoskeletal molecules, these 
molecules can accumulate under less stringent conditions: 
integrin receptor aggregation but not necessarily integrin 
ligand occupancy, although the latter may enhance the ac- 
cumulation. These findings raised two major questions: (1) 
Does  redistribution  and  local  accumulation  of signaling 
molecules depend  on tyrosine phosphorylation,  and  are 
there  comparable  requirements  for various  cytoskeletal 
molecules? and (2) What are the consequences of the vari- 
ous types of integrin-induced complex formation on signal 
transduction function, specifically on the SAPK/JNK path- 
way compared to the previously described integrin stimu- 
lation of the ERK1 and ERK2 members of the MAP ki- 
nase  pathway  (Chen  et  al.,  1994;  Morino  et  al.,  1994; 
Schlaepfer et al., 1994)? 
Effects of  Inhibitors on Integrin-induced Signaling and 
Cytoskeletal Protein Complexes 
Selective  inhibitors  of  kinase  and  cytoskeletal  function 
provide important  insights,  but  their effects can include 
nonspecific cytotoxic effects on cell growth, viability, and 
other processes (Uehara et al., 1986; Akiyama et al., 1987; 
Levitzki, 1990).  To reduce the likelihood of artifacts, we 
quantitated the effects of a range of concentrations of var- 
ious kinase inhibitors on integrin-mediated recruitment of 
cytoplasmic tyrosine-phosphorylated molecules into com- 
plexes, compared to et5131 integrin clustering and cytotoxic- 
ity, as measured by inhibition of cell growth or cytolysis. 
Herhimycin A  has been used as a specific inhibitor of Src 
family  tyrosine  kinases  (Uehara  et  al.,  1986),  while 
genistein is  a  more broad-spectrum inhibitor of tyrosine 
kinases as well as Src tyrosine kinase family members (Ak- 
iyama et al.,  1987).  Erbstatin analog and tyrphostins A23 
and A25 are inhibitors of the EGF (epidermal growth fac- 
tor) receptor kinase-dependent pathway (Levitzki, 1990). 
Cytochalasin D  has been used to inhibit the polymeriza- 
tion  of  actin  monomers,  and  has  been  shown  to  block 
FAK phosphorylation (Shattil et al., 1994b). 
Dose-response  curves were  obtained  after  incubation 
with agents for 24 h, comparing the aggregation of total ty- 
rosine-phosphorylated  proteins  induced  by  fibronectin- 
coated beads with the clustering of ~5 and 131 integrin sub- 
units.  Cell number and cytotoxic effects visible by phase 
contrast microscopy were also monitored simultaneously. 
Maximal concentrations that showed minimal cytotoxic ef- 
fects were chosen based on the cell count data and mor- 
Figure 4.  Aggregation  of signal transduction  molecules induced 
by individual ligand-coated beads.  (A) Immunofluorescence  for 
juxtamembrane  accumulation  of ERK2 and  JNK1  induced  by 
beads coated with fibronectin comparing controls (no agent: de- 
scribed as untreated), 900 nM herbimycin A, 140 p.M genistein, 
or 300 nM cytochalasin D. Each inset shows a higher magnifica- 
tion view, focusing on the equator of the bead marked by a high- 
lighted  black  arrowhead;  white  arrowhead indicates  a  second 
bead bound to the cell. Localization of ERK2 and JNK1 is de- 
tected adjacent  to fibronectin-coated  beads  (a and b). Lack of 
ERK2  and  JNKI  immunolocalization  adjacent  to  fibronectin- 
coated beads observed after treatment with herbimycin A (c and 
d), genistein (e and f), or cytochalasin D (g and h). 
phological observations in Fig. 2  and its legend: 900 nM 
herbimycin A, 140 ~M genistein, 200 p,M tyrphostin A23, 
200 ~M tyrphostin A25, and 2.5 txg/ml erbstatin analog. At 
these  concentrations, frequencies  of fibronectin-induced 
clustering of ot  5 and 131 were similar to those in untreated 
controls (Fig. 2 and data not shown). 
At  these  concentrations  of  both  herbimycin  A  and 
genistein, the aggregation of total tyrosine-phosphorylated 
proteins was markedly inhibited (Fig. 2). In contrast, max- 
imal  or  even  moderately  cytotoxic levels  of  tyrphostin 
A23, tyrphostin A25, and erbstatin analog showed signifi- 
cant continued bead-induced aggregation of total tyrosine- 
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induced  accumulation  of the signaling 
molecules  RhoA,  Racl,  Grb2,  Sos, 
Ras,  Raft,  MEKK,  MEK1,  ERK1, 
ERK2,  and  JNK1  by  immunofluores- 
cence  microscopy  in  controls  (no 
agent: described as untreated)  or cells 
treated  with  herbimycin  A,  genistein, 
or cytochalasin  D.  The  ordinate  indi- 
cates the percentage  of beads  positive 
for immunofluorescence for each anti- 
gen listed on the abscissa; values indi- 
cate  mean  and  standard  deviation. 
Polystyrene beads were coated with fi- 
bronectin,  GRGDSPC  peptide  disul- 
fide-conjugated  to  IgG,  adhesion- 
blocking antibodies mAb  16 to the a5 
subunit and mAb 13 to the [31 subunit, 
noninhibitory  antibodies  mAb  11  to 
the a5 subunit and mAb K20 to the 13l 
subunit,  and  Con  A  or  polylysine  as 
controls. 
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Figure 5.  Stimulation of ERK and JNK activity by integrin aggregation and effects of inhibitors. Time course of tyrosine phosphoryla- 
tion for total cell lysates (A). The activation of ERK (B) and SAPK/JNK (C) was determined after incubation of cells with fibronectin- 
coated beads for 0, 10, 20, 30, 40, 60, 90, or 120 min. Activation of ERK (D) and JNK (E) was analyzed after incubation for 30 rain or 10 
rain, respectively, as follows: in the absence of beads (lane 1); with BSA-coated beads (lane 2), Con A-coated beads (lane 3), polylysine- 
coated beads (lane 4), polylysine-coated beads coincubated with GRGDS peptide at 500 ~g/ml for 1 h (lane 5), noninhibitory anti-J31 
mAb K20-coated beads (lane 6), noninhibitory anti-as mAb ll-coated beads (lane 7), adhesion-blocking anti-J31 mAb 13-coated beads 
(lane 8), adhesion-blocking anti-as mAb 16-coated beads (lane 9), fibronectin-coated beads (lane 10), or beads coated with GRGDSPC 
peptide disulfide conjugated to IgG (lane 11). Effects of inhibitors on the activation of ERK (F) and SAPK/JNK (G) were analyzed in 
the absence of beads (lane 1), in the presence of polylysine-coated beads (lane 2), in the presence of fibronectin-coated beads without 
any inhibitor (lane 3), with 900 nM herbimycin A (lane 4), 140 ~M genistein (lane 5), 200 p.M tyrphostin 23 (lane 6), or 300 nM cytocha- 
lasin D (lane 7). Similar results were obtained in 3-5 independent experiments. 
phosphorylated  proteins,  F-actin,  and  c-Src  (Fig.  2  and 
data not shown). At a  concentration  of 300 nM cytochala- 
sin D, the aggregation of ~5 and 131 integrin was similar to 
controls, but the accumulation of tyrosine-phosphorylated 
proteins was inhibited  (Fig. 2). 
At the optimal concentrations  derived above, inhibition 
of  tyrosine  phosphorylation  of  individual  proteins  by 
Western  immunoblotting  using  antibody  to  phosphoty- 
rosine  was confirmed:  strong  inhibition  of tyrosine  phos- 
phorylation was observed in cells treated with 900 nM her- 
bimycin  A  and  140  p~M  genistein,  whereas  tyrosine 
phosphorylation  of major  bands  was not  inhibited  in  the 
cells treated by 200 ~M tyrphostin A23,200 ~M tyrphostin 
A25, and 2.5  ~g/ml erbstatin analog; cytochalasin D  treat- 
ment  significantly  inhibited  total  cellular  tyrosine  phos- 
phorylation  at  concentrations  above  300  nM  (data  not 
shown). 
Selective Effects of lnhibitors on Aggregation of 
Cytoskeletal and Signal Transduction Molecules 
Cytoskeletal  proteins  and  signaling  molecules  could  be 
separated into distinct classes depending on their response 
to  tyrosine  kinase  inhibitors,  cytochalasin  D,  and  ligand 
occupancy.  None  of the  tyrosine  kinase  inhibitors  or  cy- 
tochalasin D  affected the accumulation of the cytoskeletal 
The Journal of Cell Biology, Volume 131,  1995  800 Figure 6.  Summary model for integrin-mediated redistribution of cytoskeletal and signal transduction molecules. (A) Out of 29 cyto- 
skeletal and signaling molecules, only tensin and FAK show redistribution and focal accumulation after integrin aggregation in the ab- 
sence of occupancy and specific tyrosine phosphorylation. (B) Occupancy with ligand induces the accumulation of talin, a-actinin, and 
vinculin in addition to the first-stage molecules tensin and FAK, even in the absence of a tyrosine phosphorylation step. (C) Even in ab- 
sence of ligand occupancy, integrin aggregation and specific tyrosine phosphorylation result in foca! accumulation of at least 19 signal 
transduction molecules besides  FAK, as well as activating signaling  via both ERK and SAPK/JNK with different time courses. (D) If 
ligand occupancy is also present, signaling  is accompanied by massive cytoskeletal protein accumulation. Note that for direct compari- 
sons, integrins are only considered in the aggregated state for each condition; see text for discussion  of the roles of such aggregation, as 
well as the separate function of receptor ligand occupancy alone. 
protein (and Src substrate)  tensin at sites of integrin clus- 
tering induced by bead substrates  of fibronectin, multiva- 
lent  ligands,  adhesion-blocking  antibodies,  or  noninhibi- 
tory antibodies (Fig. 3, A  and B). Three more cytoskeletal 
proteins, talin, et-actinin, and vinculin, were similarly resis- 
tant to all of these inhibitors,  but their accumulation was 
dependent  on  substrates  that  provided  receptor  occu- 
pancy:  no  accumulation  of talin,  ct-actinin,  and  vinculin 
was detected  after  clustering  of integrins  with  noninhibi- 
tory antibodies in untreated or treated cells with herbimy- 
cin A, genistein, or cytochalasin D  (Miyamoto et al., 1995 
and data not shown). Finally, a marked inhibition of accu- 
mulation  of a  class of three  other cytoskeletal  molecules 
was detected after treatment with herbimycin A, genistein, 
or cytochalasin D: F-actin, paxillin  (also a  Src substrate), 
and filamin did not accumulate after treatment with these 
agents,  but  there  was no effect  after  treatment  with  tyr- 
phostin A23, tyrphostin A25, or erbstatin analog (Fig. 3 B 
and data not shown). 
Signal  transduction  molecules  fell  into  three  classes, 
with no differences due to ligand occupancy. Several mole- 
cules  (a-tubulin,  LDH, c-Lyn, and protein kinase  A) did 
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Redistribution of Cytoplasmic Proteins by lntegrins 
A  B  C  D 
Cytoskeletal 
molecules 
Src  Tensin 
substrates  FAK 
SrcKinase  I 
family 
Signaling 
molecules 
Talin 
a-actinin 
Vinculin 
Tensin 
FAK 
F-actin 
Paxillin 
Filamin 
Talin 
a-actinin 
Vinculin 
Tensin  Tensin 
FAK  FAK 
Cortactin  Cortactin 
ppl20  ppl20 
c-Src  c-Src 
c-Yes  c-Yes 
c-Fyn  c-Fyn 
c-Csk  c-Csk 
GAP  GAP 
PLC-',/  PLC-~/ 
PI 3-kinase  PI 3-kinase 
PTP-1D  PTP-1D 
RhoA  RhoA 
Rac 1  Rac 1 
Grb2  Grb2 
Sos  Sos 
Ras  Ras 
Rafl  Rafl 
MEKK  MEKK 
MEK1  MEK1 
ERK 1  ERK 1 
ERK2  ERK2 
JNK1  JNK1 
A, Integrin aggregation; B. Integrin aggregation plus integrin occupancy; C, lntegrin 
aggregation plus tyrosine phosphorylation; D, Integrin aggregation plus integrin occu- 
pancy, tyrosine phosphorylation, and actin cytoskeletal integrity. 
Not redistributed: a-Tubulin, c-Lyn, PKA, LDH. 
not show accumulation near beads even with a combina- 
tion  of receptor  occupancy and  aggregation  (Fig.  1  B, 
Miyamoto et al., 1995, and data not shown). Twenty other 
signaling-related molecules  accumulated in  response  to 
simple integrin clustering by noninhibitory antibodies. The 
aggregation  of  FAK  was  resistant  to  inhibition  by  all 
agents tested, i.e., even though genistein, herbimycin A, 
and cytochalasin D  inhibited total tyrosine phosphoryla- 
tion, FAK aggregation was  unchanged. In striking con- 
trast, each of these three agents markedly inhibited the ac- 
cumulation  of  other  Src  substrates  including p120  and 
cortactin, of members of the Src kinase family including 
c-Src,  c-Fyn, and c-Yes,  and of other types of signaling 
molecules including GAP, PI 3-kinase, PLC-'v, c-Csk, and 
PTP-1D. Moreover, molecules implicated in the MAP ki- 
nase pathways, ERK1, ERK2, and JNK1, were also sensi- 
tive  to  inhibition  (see  following section).  These  results 
were obtained regardless of whether the experimental in- 
duction of aggregation was triggered by beads coated with 
fibronectin, multivalent RGD ligands, adhesion-blocking 
antibodies, or noninhibitory antibodies (Fig. 3 B). These 
immunolocalization results were further confirmed by di- 
rectly analyzing the proteins that remained associated with 
fibronectin-coated beads after detergent extraction: after 
treatment with either genistein or herbimycin A, no signif- 
icant binding to beads-associated complexes could be de- 
tected of GAP, PI 3-kinase, ERK1, or ERK2, as deter- 
mined by Western immunoblotting (data not shown). 
To summarize this section, these results establish the ex- 
istence of distinct hierarchies of independence or depen- 
dence upon tyrosine phosphorylation, actin microfilament 
integrity, and ligand occupancy for redistribution and focal 
juxtamembrane  accumulation.  The  cytoskeletal protein 
tensin and the kinase FAK were unique in their need for 
only integrin receptor  aggregation; talin, c(-actinin,  and 
vinculin  required  the  addition  of integrin  ligand  occu- 
pancy; in  contrast, other  cytoskeletal proteins  (3  more) 
and signaling molecules (19 more) failed to accumulate af- 
ter treatment with certain tyrosine kinase inhibitors or cy- 
tochalasin.  In  addition,  the  cytoskeletal protein  tubulin 
and the signaling protein c-Lyn were not aggregated by in- 
tegrin ligation under any conditions. 
Comparisons of Signaling Pathways: Physical 
Aggregation and Function 
We next focused on a series of other proteins implicated in 
tyrosine kinase signaling cascades. Marked focal aggrega- 
tion of RhoA, Racl, Ras, Rafl, Grb2, Sos, MEK kinase 
(MEKK), MEK1, ERK1, ERK2, and JNK1 could be ex- 
perimentally induced by any of the specific integrin-inter- 
action molecules fibronectin, multivalent RGD ligand, ad- 
hesion-blocking antibodies, and noninhibitory antibodies, 
but not by concanavalin A or polylysine (Fig. 4, A and B). 
Aggregation of all 11  of these signal transduction mole- 
cules was inhibited by the tyrosine kinase inhibitors herbi- 
mycin A and genistein, as well as by cytochalasin D (Fig. 4 
B). Treatment with cycloheximide alone can induce acti- 
vation of the SAPK/JNK pathway (Coso et al.,  1995). In 
this study, cycloheximide itself also partially activated the 
SAPK/JNK pathway, but not the ERK pathway, in human 
foreskin fibroblasts (data not shown). Nevertheless, there 
was  no  quantitative  difference  in  the  aggregation  of 
ERK1, ERK2, and JNK1 in the presence or absence of cy- 
cloheximide (data not shown). 
To evaluate mechanisms of integrin activation of ERK 
and potentially of SAPK/JNK, assays specific for each ki- 
nase were performed to compare time courses, responses 
to  each  type of bead,  and  inhibition by herbimycin A, 
genistein, or cytochalasin D. Both classes of kinase were 
activated by integrin ligation by fibronectin in a  tempo- 
rally distinct fashion. ERK activation was maximal at 30 
min  and  dissipated  completely  by  60  min  (Fig.  5  B), 
whereas  activity  of  SAPK/JNK  reached  a  rapid  peak 
within 10 min and gradually declined afterwards (Fig. 5 C). 
In contrast, enhanced total cellular tyrosine phosphoryla- 
tion was detected from 10 rain through 120 min (Fig. 5 A). 
For comparisons of roles of aggregation and ligand oc- 
cupancy, assays for ERK were performed at the peak time 
of 30 min, while SAPK/JNK was assayed after incubation 
for 10 rain. No reproducible differences could be detected 
between  activation  by  fibronectin,  multivalent  RGD 
ligand,  adhesion-blocking  antibodies,  and  noninhibitory 
antibodies; polylysine and concanavalin A  were nonacti- 
vating (Fig. 5, D and E). 
Each of the agents that inhibited accumulation of these 
kinases, herbimycin A, and genistein, blocked the activa- 
tion of both types of MAP kinase (ERK and SAPK/JNK) 
caused by binding to fibronectin-coated beads (Fig. 5, F 
and G). Cytochalasin D  inhibited activation of the ERK 
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pathway (Fig. 5, F  and G). However, the addition of cy- 
tochalasin  D  alone  stimulated  the  SAPK/JNK  pathway 
even without the addition of fibronectin-coated beads, but 
cytochalasin D  did not activate the ERK pathway (data 
not shown), suggesting further differences between these 
pathways.  Thus,  integrins can mediate the  activation of 
two distinct serine/threonine kinase pathways with differ- 
ent time courses and different responses to disruption of 
the actin cytoskeleton. 
Discussion 
Our major new conclusions from these studies on mecha- 
nisms of integrin transmembrane action are as follows: (a) 
Aggregation of integrin receptors, even in the absence of 
ligand occupancy, is sufficient to induce a prompt trans- 
membrane accumulation of a large class of at least 20 sig- 
nal transduction molecules, including c-Src, c-Fyn, RhoA, 
Racl,  Ras,  GAP,  MEK1,  ERK1,  ERK2,  and  JNK1.  In 
contrast, c-Lyn was not responsive to integrin clustering. 
(b) Integrin aggregation with or without ligand occupancy 
also triggers activation of both ERK and SAPK/JNK sig- 
nal transduction pathways, but with different time courses 
of maximal stimulation and different responses to cytocha- 
lasin D, suggesting distinct mechanisms. (c) The accumula- 
tion of most signal transduction molecules as well as acti- 
vation of both ERK and SAPK/JNK pathways are blocked 
by two selective tyrosine kinase inhibitors, and all but the 
latter are also blocked by disruption of actin cytoskeletal 
organization by cytochalasin. However, the accumulation 
of FAK (focal adhesion kinase) is not blocked by any of 
these agents, indicating a distinct mechanism of interaction 
for this kinase. (d) Tyrosinc kinase-mediated phosphory- 
lation and actin cytoskeletal integrity, as well as integrin 
occupancy  and  aggregation,  are  required  for  integrin- 
induced accumulation of one group of three cytoskeletal 
components: F-actin, paxillin, and filamin. (e) In contrast, 
integrin-induced aggregation of a second group of four cy- 
toskeletal proteins  comprised  of tensin,  talin,  c~-actinin, 
and vinculin can proceed even after inhibition of the ty- 
rosine  phosphorylation  necessary  for  accumulation  of 
other signaling and cytoskeletal molecules. (f) Talin, c~-ac- 
tinin, and vinculin comprise a unique subset of three cy- 
toskeletal  proteins  whose  membrane  accumulation  re- 
quires both integrin aggregation and occupancy, but not 
the tyrosine kinase activity needed for many other inte- 
grin-responsive proteins. 
The  binding  of ligand-coated  beads  provides  a  rapid 
method  for experimentally triggering  strong  transmem- 
brane adhesive complexes based on receptor contacts with 
extracellular matrix that mimic focal and matrix adhesions 
(Mueller et al., 1989; Plopper and Ingber, 1993; Lewis and 
Schwartz,  1995).  This process can be distinguished  from 
phagocytosis by a strong juxtamembrane accumulation of 
myosin II (unpublished data), compared to the absence of 
myosin II adjacent to classical phagocytic vesicles (Brown, 
1995). The findings in this study, when combined with the 
previously established function of ligand occupancy alone 
in  fibroblasts  (LaFlamme  et  al.,  1992  and  references 
therein), allow us to distinguish a minimum of at least six 
distinct molecular classes of transmembrane response to 
cell surface integrin interactions. Besides unique responses 
to integrin occupancy alone and its synergy with aggrega- 
tion, Fig. 6 shows three additional states; some molecules 
have no response to any of these stimuli. 
Although  not  contradictory to previous studies,  these 
classifications based on functional responses to integrin in- 
teractions identify novel categorical groupings of over 30 
cytoskeletal and signaling molecules (Table I). FAK was 
the only tyrosine kinase out of five tested (c-Src, c-Fyn, 
c-Yes, c-Csk, and FAK) that could associate with integrin 
clusters  upon  inhibitory  tyrosine  phosphorylation  by 
genistein or herbimycin A. This kinase can bind to 131 inte- 
grin cytoplasmic tails in vitro (Schaller and Parsons, 1994), 
and this association appears more proximal than the two 
other molecules known to bind to this integrin intracellu- 
lar domain, i.e., talin and ct-actinin (Horwitz et al., 1986; 
Otey et al., 1990; but see also Lewis and Schwartz, 1995). 
Although this central positioning of FAK suggests an im- 
portant early role in fibroblast integrin responses, platelet 
FAK phosphorylation appears to be relatively late in the 
sequence  of  phosphorylation  events  that  occur  during 
platelet activation (e.g., compare Schaller et al., 1992 with 
Huang et al., 1993). 
Even though tensin is  a  tyrosine kinase  substrate  like 
paxillin, pp120, and cortactin (Schaller et al.,  1993), it has 
unique  characteristics  in  integrin-mediated  localization 
studies. No other tyrosine kinase substrate  (except FAK 
itself) or cytoskeletal protein shows this resistance to inhi- 
bition of tyrosine phosphorylation or disruption of actin 
cytoskeletal integrity. 
Our previous study demonstrated that talin, c~-actinin, 
paxillin, F-actin, and other cytoskeletal molecules require 
both integrin aggregation and ligand occupancy for accu- 
mulation (Miyamoto et al.,  1995).  The present study now 
identifies  two  distinct  classes  among  these  molecules. 
Talin, et-actinin, and vinculin comprise a unique group of 
molecules that  is  able  to  accumulate focally even if ty- 
rosine phosphorylation is inhibited by genistein or herbi- 
mycin A, and even if actin-related processes are disrupted 
by cytochalasin D. Since talin and ct-actinin have the ca- 
pacity to  interact  with  [31  integrin  cytoplasmic domains 
(Horwitz  et  al.,  1986;  Otey  et  al.,  1990;  Lewis  and 
Schwartz, 1995), it is possible that the three molecules can 
accumulate in direct association with integrins once the re- 
quirements of clustering and occupancy are fulfilled; vin- 
culin might associate via binding to et-actinin or talin (e.g., 
see Burridge et al., 1988). Tyrosine phosphorylation inhib- 
itable by genistein and herbimycin A  would, thus, not be 
involved in this process. 
Paxitlin, F-actin, and filamin form another distinct group 
of cytoskeletal molecules that require all three types of in- 
put, i.e., tyrosine kinase-mediated functions in addition to 
integrin aggregation and occupancy. The biologically im- 
portant association of F-actin with integrins is  therefore 
likely to be subjected to maximal regulatory modulation 
because of this mandatory tripartite input. Paxillin can be 
tyrosine phosphorylated via FAK,  and has binding sites 
for vinculin, c-Src, v-Crk, and c-Csk (e.g., see Clark and 
Brugge, 1995).  It is possible that the aggregation of paxil- 
lin provides a mechanism for regulating cytoskeletal orga- 
nization, accompanied by aggregation of signaling mole- 
cules. 
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molecules  required  integrin  aggregation,  but  not  occu- 
pancy. This pattern was consistent with that of FAK and 
tensin.  However,  in marked contrast to these  two mole- 
cules, the accumulation process was blocked by the inhibi- 
tors of Src kinases, genistein and herbimycin A, but not by 
other tyrosine kinase inhibitors. Puzzlingly, disruption of 
actin  cytoskeletal  integrity  by  cytochalasin  D  also  dis- 
rupted this accumulation, as has been observed in platelets 
(Shattil et al., 1994b). The effect is accompanied by inhibi- 
tion of overall tyrosine phosphorylation detected by West- 
ern blotting, suggesting a role for tyrosine phosphorylation 
in the mechanism.  It is important to note that this effect 
was found even under conditions where accumulations of 
actin  were  not  present  (which  requires  an  additional 
ligand occupancy step). Cells have ubiquitous F-actin fila- 
ment systems in the cell cortex near where integrin-cyto- 
plasmic  interactions  take  place.  Some  actin-dependent 
process may be required for local tyrosine phosphorylation. 
Small GTP-binding proteins including RhoA, Racl, and 
Ras are aggregated  at the sites of contact with beads, ac- 
companied by tyrosine phosphorylation  (Fig. 4 B). Addi- 
tionally, Grb2, Sos, Rafl, MEKK, MEK1, ERK1, ERK2, 
and JNK1 are recruited by integrin aggregation. The MAP 
kinases  ERK  (Chen  et  al.,  1994;  Morino  et  al.,  1994; 
Schlaepfer  et  al.,  1994;  and  this  study)  and  SAPK/JNK 
(this study) are activated by this integrin aggregation.  In- 
terestingly,  even  though  these  two types of signaling  ki- 
nase are associated with quite distinct signaling pathways, 
i.e., growth factors vs inflammatory cytokines or stress, re- 
spectively (Minden et al., 1994; Sanchez et al., 1994; Yan et 
al., 1994), integrin aggregation can activate both pathways, 
albeit with differing time courses.  In fibroblasts, cell  at- 
tachment  on fibronectin activates  the NF-KB  p50/65  het- 
erodimer, which is shown to be  mediated  by  a  pathway 
involving Src tyrosine kinases and the Ha-Ras small GTP- 
binding protein  (Devary  et al.,  1993;  Qwarnstrom  et  al., 
1994).  Integrins may therefore simultaneously induce the 
activation of a variety of signal transduction pathways, as 
would also be suggested by the broad spectrum of signal- 
ing molecules  that  accumulate  at integrin-induced  trans- 
membrane complexes. 
The existence of distinct groups or hierarchies of various 
signaling pathways provides a remarkable diversity of po- 
tential mechanisms for mediating the molecular responses 
to integrin ligation or aggregation, involving various com- 
binations  of  cytoskeletal  and  signal  transduction  mole- 
cules. 
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